Key Highlights
- Max Reinhardt appointed President of Global Spine business at Orthofix Medical Inc.
- Effective date: June 10, 2024
- Reinhardt’s 30+ years in MedTech and pharmaceuticals
- Past roles include Worldwide President at DePuy Synthes Spine
- Experience with Steris, Olympus, and Pacira Biosciences
Source: Business Wire
Notable Quotes
- “Max brings strong leadership and a proven track record of success to our global spine business.” – Massimo Calafiore, President and CEO at Orthofix Medical Inc
- “I believe the company has a strong foundation and is well positioned for growth in the years ahead. I look forward to working with our dedicated team members to deliver new product solutions and provide exceptional support for our surgeon customers and their patients.” – Max Reinhardt, President of the Global Spine Business at Orthofix
SoHC's Take
The appointment of Max Reinhardt as President of the Global Spine business at Orthofix marks a significant step for the company. With over three decades of experience in MedTech and pharmaceuticals, Reinhardt’s proven track record at top companies like Johnson & Johnson, Steris, and Pacira Biosciences positions him well to drive innovation and growth. His leadership is expected to enhance Orthofix’s market position and foster the development of new product solutions. This strategic move underscores Orthofix’s commitment to maintaining its leading status in the spine and orthopedics sector.
